News

Paxlovid antiviral therapy reduces risk of long COVID

By November 8, 202262 views

A network of molecules and atoms of glass and crystals constitute a single system. 3D illustration

In a recent study posted to the medRxiv* server, researchers in Saint Louis, Missouri, examined whether nirmatrelvir treatment reduced the risk of long COVID, the disease encompassing the post-acute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [PASC].